Recombinant Human EGF Protein (FITC)

Features and benefits
  • Expression System: Pichia pastoris
  • Protein Tag: No tag
  • Bioactivity: Binding EGFR
Item Number
rp170192
Grouped product items
SKUSizeAvailabilityPrice Qty
rp170192-10μg (Trial Size)
Apply for free trial size(?)
Every year, as a valued customer, you have the exclusive opportunity to explore and enjoy three different trial products of your choice, absolutely free!
10μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$599.90
rp170192-20μg
20μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$999.90

EGF-FITC, Active, Pichia pastoris, No tag, 971-1021aa

Basic Description

Product NameRecombinant Human EGF Protein (FITC)
Synonymsbeta-urogastrone | EGF | epidermal growth factor (beta-urogastrone) | epidermal growth factor | hEGF | HOMG4 | pro-epidermal growth factor | URG | Urogastrone | EGF
GradeActiBioPure™, Azide Free, Bioactive
Product Description

Introduction:
Epidermal growth factor (EGF) is a hormone that stimulates division of epidermal and other cells. EGF (FITC) conjugate, which remains fully active after conjugation and can be used to study EGF receptor in cells. Fluorescently labeled EGF has enabled researchers to investigate receptor-membrane interactions, study receptor distribution, calculate rate constants for the interaction of EGF with its receptor, and more.
Conjugation:
The EGF was conjugated with FITC under optimum conditions, and unreacted FITC was removed. The number of fluorophore molecules on each EGF molecule is 1.0.
Recommended Usage:
Fluorescence is typically monitored using a flow cytometer, fluorescence microscope, or fluorimeter. For immunofluorescent staining, the recommended use of this reagent is ≤ 0.5µg per million cells in 100 µl staining volume. It is recommended that the reagent be titrated for optimal performance for different cell lines.

Specifications & PurityActiBioPure™, Bioactive, Azide Free
BioactivityBinding EGFR
Expression SystemPichia pastoris
SpeciesHuman
Amino Acids971-1021 aa
SequenceNSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWE
Protein TagNo tag
ConjugationFITC

Product Specifications

FormLyophilized
ReconstitutionThis product should be reconstituted in 100μL of deionized water to make a 0.2mg/mL stock solution. Prepare working dilution on day of use. Stock solution is stable for about 8 weeks at 2-8°C as an undiluted liquid. Avoid freeze-thaw cycles. Protect fluor
Storage TempProtected from light,Store at -20°C
Shipped InIce chest + Ice pads
Stability And StorageThe lyophilized products should be stored at –20°C until use. Allow the product to warm to room temperature before opening. Protect from light. When stored properly, the products should be stable for at least 12 months.

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeDateItem
ZJ23R0700043Certificate of AnalysisJul 17, 2023 rp170192

Related Documents

References

1. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M et al..  (2002)  Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains..  Cell,  110  (6): (775-87).  [PMID:12297050] [10.1021/op500134e]
2. Lesuisse D, Mauger J, Nemecek C, Maignan S, Boiziau J, Harlow G, Hittinger A, Ruf S, Strobel H, Nair A, Ritter K, Malleron JL, Dagallier A, El-Ahmad Y, Guilloteau JP, Guizani H, Bouchard H, Venot C..  (2011)  Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors..  Bioorg Med Chem Lett,  21  (8): (2224-2228).  [PMID:21441024] [10.1016/j.bmcl.2011.03.003]
3. Gregory, H H and Preston, B M BM..  (1977)  The primary structure of human urogastrone..  International journal of peptide and protein research,      [PMID:300079]
4. Hommel, U U, Harvey, T S TS, Driscoll, P C PC and Campbell, I D ID..  (1992)  Human epidermal growth factor. High resolution solution structure and comparison with human transforming growth factor alpha..  Journal of molecular biology,    (5):   [PMID:1522591]
5. Furuya, M M, Akashi, S S and Hirayama, K K..  (1989)  The primary structure of human EGF produced by genetic engineering, studied by high-performance tandem mass spectrometry..  Biochemical and biophysical research communications,    (15):   [PMID:2789514]
6. Bell, G I GI and 8 more authors..  (1986)  Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization..  Nucleic acids research,    (11):   [PMID:3491360]
7. Lu, H S HS and 5 more authors..  (2001)  Crystal structure of human epidermal growth factor and its dimerization..  The Journal of biological chemistry,    (14):   [PMID:11438527]
8. Ferguson, Kathryn M KM and 5 more authors..  (2003)  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization..  Molecular cell,      [PMID:12620237]
9. Groenestege, Wouter M Tiel WM and 10 more authors..  (2007)  Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia..  The Journal of clinical investigation,      [PMID:17671655]
10. Lu, Chafen C and 6 more authors..  (2010)  Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor..  Molecular and cellular biology,      [PMID:20837704]
11. Huang, Hsiao-Wen HW, Mohan, Sepuru K SK and Yu, C C..  (2010)  The NMR solution structure of human epidermal growth factor (hEGF) at physiological pH and its interactions with suramin..  Biochemical and biophysical research communications,    (26):   [PMID:21029725]
12. Zettl, Markus M, Adrain, Colin C, Strisovsky, Kvido K, Lastun, Viorica V and Freeman, Matthew M..  (2011)  Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling..  Cell,    (1):   [PMID:21439629]

Solution Calculators